Nonvascular Complications of Injectable Fillers—Prevention and Management

Abstract

Injectable filler treatments have increased in popularity because of enhanced safety profile and improved physical characteristics. ISAPS (International Society of Plastic Surgery) put out global data showing 3.7 million hyaluronic acid (HA) filler procedures in 2018, making it the second most often performed procedure in the world, after botulinum toxin. And these are only ‘those’ performed by qualified plastic surgeons. There was a concomitant increase in both the nonvascular and vascular complications, which coincided with the number and type of filler procedures performed. Filler complications were reviewed from existing literature, and an attempt was made to understand etiology, elucidate clinical features, and clarify optimum treatment strategies for each. Complications can be early or delayed in presentation, early consisting of injection site complications like bruising, edema, and hypersensitivity, Tyndall effect, and intravascular injection. Delayed complications included hypersensitivity type IV, acute infections like cellulitis, abscesses, and herpes and delayed ones like granulomas, biofilms, and atypical mycobacterial infections. These were analyzed and treatment options, protocols, and consensus guidelines were suggested. A clear understanding of facial anatomy, physical characteristics of all fillers used, early recognition, and treatment options of complications will ensure optimum outcomes.

Keywords

fillers - injectable fillers - complications - nonvascular - hypersensitivity - infection - biofilm - atypical mycobacteria

Publikationsverlauf

Artikel online veröffentlicht:
24. Dezember 2020

• References

• 1 Aesthetic Surgery National Data Bank. Available at: https://www.surgery.org/sites/default/files/ASAPS-Stats 2018_0.pdf. Accessed September 7, 2020
• 2 ISAPS Global Statistics 2018. Available at: https://www.isaps.org/wp-content/uploads/2018/10/ISAPS_2017_International_Study_Cosmetic_Procedures.pdf. Accessed September 7, 2020
• 3 Chandawarkar AA, Provenzano DJ, Rad AN, Sherber NS. Learning curves: historical trends of FDA-reported adverse events for dermal fillers. Cutis 2018; 102 (02) E20-E23
• 4 Swift A, Delorenzi C, Kapoor KM, Injection anatomy: avoiding the disastrous complication. In: Jones DH, Swift A, eds. From ‘Injectable Fillers-Facial Shaping and Contouring’. 2nd ed. Oxford, United Kingdom: Wiley Blackwell; 2019
• 5 MAUDE-Manufacturer and User Facility Device Experience. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.CFM. Accessed September 7, 2020
• 6 (NHS) Health Education England. Part One. Qualification Requirements for Delivery of Cosmetic Procedures: Non-surgical Cosmetic Interventions and Hair Restoration Surgery. London: 2015
• 7 (NHS) Health Education England. Part two. Report on Implementation of Qualification Requirements for Cosmetic Procedures: Non-surgical Cosmetic Interventions and Hair Restoration Surgery. London: 2015
• 8 Hachach-Haram N, Gregori M, Kirkpatrick N, Young R, Collier J. “Complications of facial fillers: resource implications for NHS hospitals,” Case Reports, vol. 2013 article bcr-2012– 007141, 2013
• 9 Stern R, Maibach HI. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. Clin Dermatol 2008; 26 (02) 106-122
• 10 Sudha PN, Rose MH. Beneficial effects of hyaluronic acid. Adv Food Nutr Res 2014; 72: 137-176
• 11 Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 2008; 10 (01) 35-42
• 12 Buhren BA, Schrumpf H, Hoff N-P, Bölke E, Hilton S, Gerber PA. Hyaluronidase: from clinical applications to molecular and cellular mechanisms. Eur J Med Res 2016; 21 (05) 5
• 13 Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J 2010; 30 (02) 235-238
• 14 Fitzgerald R, Vleggaar D. Facial volume restoration of the aging face with poly-l-lactic acid. Dermatol Ther (Heidelb) 2011; 24 (01) 2-27
• 15 Daines SM, Williams III EF. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review. JAMA Facial Plast Surg 2013; 15 (03) 226-231
• 16 Gladstone HB, Cohen JL. Adverse effects when injecting facial fillers. Semin Cutan Med Surg 2007; 26 (01) 34-39
• 17 King M, Walker L, Convery C, Davies E. Management of a vascular occlusion associated with cosmetic injections. J Clin Aesthet Dermatol 2020; 13 (01) E53-E58
• 18 Zeichner JA, Cohen JL. Use of blunt tipped cannulas for soft tissue fillers. J Drugs Dermatol 2012; 11 (01) 70-72
• 19 Shah NS, Lazarus MC, Bugdodel R. et al. The effects of topical vitamin K on bruising after laser treatment. J Am Acad Dermatol 2002; 47 (02) 241-244
• 20 Elson ML. Soft tissue augmentation. A review. Dermatol Surg 1995; 21 (06) 491-500, quiz 501–502
• 21 Vedamurthy M. Beware what you inject: complications of injectables—dermal fillers. J Cutan Aesthet Surg 2018; 11 (02) 60-66
• 22 Duranti F, Salti G, Bovani B, Calandra M, Rosati ML. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg 1998; 24 (12) 1317-1325
• 23 Van S Dyke, Hays GP, Caglia AE, Caglia M. Severe acute local reactions to a hyaluronic acid-derived dermal filler. J Clin Aesthet Dermatol 2010; 3 (05) 32-35
• 24 King M. Management of edema. J Clin Aesthet Dermatol 2017; 10 (01) E1-E4
• 25 Arron ST, Neuhaus IM. Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid. J Cosmet Dermatol 2007; 6 (03) 167-171
• 26 Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol 2013; 6: 295-316
• 27 Hilton S, Schrumpf H, Buhren BA, Bölke E, Gerber PA. Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients. Eur J Med Res 2014; 19: 30
• 28 Funt DK. Avoiding malar edema during midface/cheek augmentation with dermal fillers. J Clin Aesthet Dermatol 2011; 4 (12) 32-36
• 29 Christensen L, Breiting V, Bjarnsholt T. et al. Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery. Clin Infect Dis 2013; 56 (10) 1438-1444
• 30 Sherman RN. Avoiding dermal filler complications. Clin Dermatol 2009; 27: S23-S32
• 31 Pratt RJ, O’Malley B. Supporting evidence-based infection prevention and control practice in the National Health Service in England. The NHS/TVU/Intuition Approach. J Hosp Infect 2007; 65 (suppl 2) 142-147
• 32 Rodriguez JM, Xie YL, Winthrop KL. et al. Mycobacterium chelonae facial infections following injection of dermal filler. Aesthet Surg J 2013; 33 (02) 265-269
• 33 Lemperle G, Gauthier-Hazan N, Wolters M. Eisemann-Klein M, Zimmermann U, Duffy DM. Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes. Plast Reconstr Surg 2009; 123 (06) 1842-1863
• 34 Shahrabi-Farahani S, Lerman MA, Noonan V, Kabani S, Woo SB. Granulomatous foreign body reaction to dermal cosmetic fillers with intraoral migration. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117 (01) 105-110
• 35 Kaczorowski M, Nelke K, Łuczak K, Hałoń A. Filler migration and florid granulomatous reaction to hyaluronic acid mimicking a buccal tumor. J Craniofac Surg 2020; 31 (01) e78-e79
• 36 Rzany B, Becker-Wegerich P, Bachmann F, Erdmann R, Wollina U. Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use. J Cosmet Dermatol 2009; 8 (04) 317-323
• 37 Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol 2011; 64 (01) 1-34, quiz 35–36
• 38 Cassuto D, Marangoni O, De Santis G, Christensen L. Advanced laser techniques for filler-induced complications. Dermatol Surg 2009; 35 (suppl 2) 1689-1695
• 39 Grippaudo FR, Pacilio M, Di M Girolamo, Dierckx RA, Signore A. Radiolabelled white blood cell scintigraphy in the work-up of dermal filler complications. Eur J Nucl Med Mol Imaging 2013; 40 (03) 418-425
• 40 Goslee S, Wolinsky E. Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis 1976; 113 (03) 287-292
• 41 Narang R, Narang P, Mendiratta DK. Isolation and identification of nontuberculous mycobacteria from water and soil in central India. Indian J Med Microbiol 2009; 27 (03) 247-250
• 42 Palm MD, Butterwick KJ, Goldman MP. Mycobacterium chelonae infection after fractionated carbon dioxide facial resurfacing (presenting as an atypical acneiform eruption): case report and literature review. Dermatol Surg 2010; 36 (09) 1473-1481
• 43 Culton DA, Lachiewicz AM, Miller BA. et al. Nontuberculous mycobacterial infection after fractionated CO(2) laser resurfacing. Emerg Infect Dis 2013; 19 (03) 365-370
• 44 Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg 2003; 29 (09) 971-973
• 45 Das DK. Fine-needle aspiration cytology in the diagnosis of tuberculous lesions. Cytology 2000; 31 (01) 625-632
• 46 Cortesia C, Lopez GJ, de Waard JH, Takiff HE. The use of quaternary ammonium disinfectants selects for persisters at high frequency from some species of non-tuberculous mycobacteria and may be associated with outbreaks of soft tissue infections. J Antimicrob Chemother 2010; 65 (12) 2574-2581
• 47 Urdiales-Galvez F, Delgado E, Figueiredo V. et al. Treatment of soft tissue filler complications: expert consensus recommendations. Aesthetic Plast Surg 2017; 41 (03) 667-677
• 48 King M, Convery C, Davies E. This month’s guideline: the use of hyaluronidase in aesthetic practice (v2.4). J Clin Aesthet Dermatol 2018; 11 (06) E61-E68
• 49 DeLorenzi C. Complications of injectable fillers, part I. Aesthet Surg J 2013; 33 (04) 561-575
• 50 Taylor SC, Burgess CM, Callender VD. Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: a randomized, evaluator-blinded comparative trial. Dermatol Surg 2009; 35 (suppl 2) 1653-1660
• 51 Grimes PE, Thomas JA, Murphy DK. Safety and effectiveness of hyaluronic acid fillers in skin of color. J Cosmet Dermatol 2009; 8 (03) 162-168
• 52 Signorini M, Liew S, Sundaram H. et al. Global Aesthetics Consensus Group. Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers—evidence and opinion-based review and consensus recommendations. Plast Reconstr Surg 2016; 137 (06) 961e-971e